eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
mainstream reporters and editors and publishers are well aware that telling the truth and continuing to pound on it would undermine a basic institution of society.
.
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015.
.